Abstract
Duodenoscopes are used for more than 500,000 endoscopic retrograde cholangiopancreatography (ERCP) procedures annually in the United States. 1 U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/reprocessing-reusable-medical-devices/infections-associated-reprocessed-duodenoscopes. Accessed July 11, 2021. Google Scholar Although most endoscopes are susceptible to risk of infectious transmission, duodenoscopes are uniquely susceptible due to procedural considerations (frequent intervention in an infected milieu such as cholangitis and frequent removal of foreign bodies such as stents through the working channel) and scope considerations (elevator mechanism making reprocessing more complex and difficult). 2 Kovaleva J et al. Clin Microbiol Rev. 2013; 26: 231-254 Google Scholar ,3 Rubin ZA Murthy RK. Curr Opin Infect Dis. 2016; 29: 407-414 Google Scholar Since 2012, more than 25 duodenoscope-related outbreaks of multidrug-resistant organisms have occurred worldwide, infecting at least 250 people. 4 U.S. Senate. Senate Health. Education, Labor and Pensions Committee & Minority Staff Report. https://www.help.senate.gov/imo/media/doc/Duodenoscope%20Investigation %20FINAL%20Report.pdf. Accessed July 12, 2021. Google Scholar
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Techniques and Innovations in Gastrointestinal Endoscopy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
